Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_636_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •Contents
- •Contributors
- •Puborectalis Muscle
- •Iliococcygeus Muscle
- •Pubococcygeus Muscle
- •Mesorectum
- •Presacral Fascia
- •Retrosacral Fascia
- •Waldeyer’s Fascia
- •Denonvilliers’ Fascia
- •Lateral Ligaments
- •Anorectal Spaces
- •Perianal Space
- •Intersphincteric Space
- •Submucous Space
- •Ischioanal/Ischiorectal Space
- •Supralevator Space
- •Anal Canal Epithelium
- •Internal Anal Sphincter
- •Conjoined Longitudinal Muscle
- •External Anal Sphincter
- •Perineal Body
- •Pelvic Floor Muscles
- •Retrorectal Space
- •Rectal Blood Supply
- •Superior Rectal Artery
- •Middle Rectal Artery
- •Inferior Rectal Artery
- •Cecum
- •The Appendix
- •Ascending Colon
- •Transverse Colon
- •Descending Colon
- •Sigmoid Colon
- •Rectosigmoid Junction
- •Blood Supply
- •Superior Mesenteric Artery
- •Inferior Mesenteric Artery
- •Venous Drainage
- •Lymphatic Drainage
- •Nervous Innervation
- •Embryology
- •Non-rotation
- •Malrotation
- •Reversed Rotation
- •Omphalocele
- •Internal Hernias
- •Proximal Colon Duplication
- •Meckel’s Diverticulum
- •Hirschsprung’s Disease
- •Anorectal Malformations
- •Anal Stenosis
- •Membranous Atresia
- •Anal Agenesis
- •Anorectal Agenesis
- •Rectal Atresia or “High Atresia”
- •Persistent Cloaca
- •2: Colonic Physiology
- •Colonic Anatomy
- •Introduction
- •Colonic Wall Anatomy
- •Colonic Epithelial Cell Types
- •Colonic Flora
- •Electrolyte Regulation and Water Absorption
- •Short-Chain Fatty Acid Absorption
- •Secretory Role of the Colonic Epithelium
- •Regulation of Electrolyte and Water Absorption and Secretion
- •Colonic Innervation
- •Colonic Motility
- •Cellular Basis of Motility
- •Motility Patterns and Measurement
- •Introduction
- •Normal Continence
- •Rectal Capacity
- •Structural Considerations
- •Normal Defecation
- •Obstructed Defecation
- •Functional Anorectal Pain
- •4: Endoscopy
- •Introduction
- •The Complete Anorectal Examination
- •Patient Position
- •Prone Jackknife
- •Left Lateral
- •Digital Rectal Examination
- •Anoscopy/Proctoscopy
- •Anoscopy
- •Proctoscopy
- •Flexible Endoscopy
- •Flexible Endoscopic Insertion Techniques
- •Torque
- •Dithering/Jiggle
- •Slide-By
- •Special Considerations
- •The Patient Requiring Antibiotics
- •The Anticoagulated Patient
- •Incomplete Colonoscopy
- •Procedure
- •The Endoscopy Suite
- •Instruments
- •Sedation
- •Nitrous Oxide
- •Ketamine
- •Propofol
- •Colonoscopy Technique
- •Anal Intubation
- •Sigmoid Colon
- •Sigmoid-Descending Junction
- •Descending Colon
- •Splenic Flexure
- •Transverse Colon
- •Hepatic Flexure
- •Cecum
- •Patient Position
- •Abdominal Pressure
- •Sigmoidoscopy
- •Colonoscopy
- •Bowel Preparation
- •Ileocecal Valve Intubation
- •Terminal Ileum
- •Alternate Techniques
- •Chromocolonoscopy (Chromoendoscopy)
- •Full-Spectrum Endoscopy
- •Complications
- •Sedation Complications
- •Vasovagal/Cardiac Arrhythmia
- •Pulmonary
- •Procedural Complications
- •Splenic Injury
- •Perforation
- •Post-polypectomy Syndrome
- •Bleeding
- •Infectious Complications
- •Simulation
- •Documentation
- •Quality
- •PillCam Endoscopy
- •Introduction
- •Polypectomy Techniques
- •Endoscopic Mucosal Resection
- •Endoscopic Submucosal Dissection
- •Combined Endo-Laparoscopic Surgery (CELS)
- •Major Abdominal Surgery
- •Anorectal Surgery
- •Preoperative Testing
- •Laboratory Studies
- •Electrocardiogram
- •Chest X-ray
- •Initial Workup
- •Who Needs Additional Testing?
- •Preoperative “Optimization”
- •Coronary Stent Management
- •AICD/Pacemaker Management
- •COPD
- •Obstructive Sleep Apnea (OSA)
- •Diabetes
- •Obesity
- •Malnutrition
- •Solid Organ Transplant Recipients
- •Substance Abuse
- •Alcohol
- •Tobacco
- •Opioids
- •Medications
- •Anticoagulation
- •Immunosuppressive Agents
- •Chemotherapy
- •Introduction
- •Preoperative Management
- •Patient Education
- •Intraoperative Pathway
- •Minimally Invasive Colorectal Surgery
- •Intraoperative Fluid Administration
- •Analgesia
- •Venous Thromboembolism (VTE) Prophylaxis
- •Postoperative Recovery
- •Analgesia
- •Intravenous Fluid Management
- •Venous Thromboembolism (VTE) Prophylaxis
- •Quality Pathway Evaluation Measures
- •Quality Improvement Measures
- •8: Postoperative Complications
- •Introduction
- •Ureteral Injury
- •Bladder Injury
- •Urethral Injury
- •IV Fluid Management
- •Wound Management
- •Bladder Management
- •Pain Management
- •Academic Medical Center
- •Wound Complications
- •Preoperative Considerations
- •Perioperative Interventions
- •Long-Term Complications
- •Genitourinary Complications
- •Fertility Complications
- •Bowel Dysfunction
- •9: Anastomotic Construction
- •Introduction
- •Surgical Staplers
- •Handsewn Anastomoses
- •Compression Anastomoses
- •Tension
- •Blood Supply
- •Prophylactic Drainage
- •Diversion
- •High-Risk Anastomoses
- •Abdominal Anastomoses
- •Small Bowel Anastomoses
- •Ileocolic Anastomoses
- •Pelvic Anastomoses
- •Stapled Colorectal Anastomoses
- •Handsewn Colorectal Anastomosis
- •Ileorectal Anastomosis
- •Neorectal Reservoirs
- •Handsewn Coloanal Anastomosis
- •Unanticipated Pelvic Anastomosis
- •Inadequate Colonic Length
- •Intraoperative Anastomotic Failure
- •10: Anastomotic Complications
- •Anastomotic Leak
- •Overview
- •Consequences
- •Prevention
- •Diagnosis
- •Treatment
- •Anastomotic Stricture
- •Anastomotic Bleeding
- •Introduction
- •Patient History
- •Levator Syndrome
- •Physical Examination
- •Abdominal Examination
- •Inguinal Examination
- •Digital Rectal Examination
- •Conclusion
- •12: Hemorrhoids
- •Anatomy
- •Etiology
- •Epidemiology
- •Clinical Presentation
- •History
- •Physical Examination
- •Treatment
- •Medical Management
- •Dietary
- •Topical Therapies
- •Oral Therapy
- •Rubber Band Ligation
- •Infrared Photocoagulation
- •Sclerotherapy
- •Excisional Hemorrhoidectomy-Closed Technique
- •Excisional Hemorrhoidectomy Open Technique (Milligan-Morgan)
- •Excisional Hemorrhoidectomy (Circumferential or Whitehead)
- •Urinary Retention
- •Postoperative Hemorrhage
- •Anal Stenosis
- •Postoperative Infection
- •Fecal Incontinence
- •Stapled Hemorrhoidopexy
- •Transanal Hemorrhoidal Dearterialization
- •Special Clinical Scenarios
- •Thrombosed External Hemorrhoid
- •Pregnancy
- •Crohn’s Disease
- •Immunocompromised Patients
- •13: Anal Fissure
- •Pathogenesis
- •Non-operative Treatment
- •Healing Rates in Acute Anal Fissure
- •Healing Rates in Chronic Anal Fissure
- •Topical
- •Nitroglycerin
- •Calcium Channel Blockers
- •Botulinum Toxin Type A
- •Operative Treatment
- •Anal Dilation
- •Anal Sphincterotomy (Technique)
- •Outcomes Between Closed and Open Anal Sphincterotomy
- •Extent of Sphincterotomy
- •Fissurectomy
- •Results of Sphincterotomy
- •Fissures Without Anal Hypertonicity
- •Crohn’s Disease
- •Conclusions
- •Pathophysiology
- •Anatomy
- •Etiology
- •Evaluation
- •Physical Examination
- •Imaging
- •Computed Tomography (CT)
- •Magnetic Resonance Imaging (MRI)
- •Endoanal Ultrasound (EAUS)
- •Transperineal Sonography (TP-US)
- •Treatment
- •Catheter Drainage
- •Postoperative Management
- •Complications
- •Immediate Postoperative Period
- •Misdiagnosis
- •Special Considerations
- •Necrotizing Anorectal Infection (Fournier’s Gangrene)
- •Diagnosis
- •Treatment
- •Outcomes
- •Anal Fistula
- •Etiology
- •Diagnosis
- •Fistulography
- •Endoanal Ultrasound
- •Magnetic Resonance Imaging
- •Treatment
- •Lay-Open Technique (Fistulotomy)
- •Setons
- •Advancement Flap
- •Technique
- •Technique
- •Fibrin Glue
- •Technique
- •Anal Fistula Plug
- •Technique
- •Novel Techniques
- •15: Complex Anorectal Fistulas
- •Introduction
- •Complex or Recurrent Cryptoglandular Fistulas
- •Surgical Treatment
- •Seton
- •Anal Flap
- •Anal Fistula Plug
- •Fibrin Glue
- •Outcomes
- •Seton
- •Advancement Flap
- •Anal Fistula Plug
- •Fibrin Glue
- •Rectourethral Fistulas
- •Surgical Treatment
- •Transanal Approach
- •Posterior Approach
- •Transperineal Approach
- •Transabdominal Approach
- •Outcome
- •Postoperative Fistulas
- •Surgical Treatment
- •Outcome
- •16: Rectovaginal Fistula
- •Obstetric Injury
- •Cryptoglandular Disease
- •Crohn’s Disease
- •Endorectal Repairs
- •Transperineal Repairs
- •Tissue Transposition Repairs
- •Martius Flap
- •Gracilis Muscle Transposition
- •Transvaginal Repairs
- •Transabdominal Repair
- •Alternate Repairs
- •Background
- •Etiology
- •Clinical Presentation/Diagnosis
- •Treatment
- •Non-operative Management
- •Operative/Excisional Management
- •Basic Procedures
- •Complex Procedures
- •Karydakis Flap
- •Cleft Lift Procedure (See Video 17.1)
- •Rhomboid/Limberg Flap (See Video 17.2)
- •Disease Recurrence
- •Hidradenitis Suppurativa
- •Etiology/Presentation/Diagnosis
- •Treatment
- •Medical Therapy
- •Surgical/Excisional Therapy
- •Introduction
- •Irritants
- •Steroid-Inducing Itching
- •Infectious
- •Dermatologic
- •Neoplasms
- •Anorectal Conditions
- •Systemic Diseases
- •Physical Examination
- •Infectious
- •Dermatologic
- •Neoplasms
- •Biochemical Testing
- •Microbiology Testing
- •Patch Testing
- •Anoscopy: Proctoscopy
- •Biopsy
- •Evidence-Based Management
- •Primary Prutitis Ani
- •Secondary Prutitis Ani
- •Infectious
- •Dermatologic
- •Systemic Diseases
- •19: Sexually Transmitted Infections
- •Introduction
- •Perianal or Genital Lesions
- •Proctitis
- •Proctocolitis
- •Enteritis
- •Gonorrhea
- •Epidemiology
- •Clinical Presentation
- •Emerging Antibiotic Resistance
- •Chlamydia
- •Epidemiology
- •Clinical Presentation
- •Lymphogranuloma Venereum
- •Epidemiology
- •Clinical Presentation
- •Treatment
- •Syphilis
- •Epidemiology
- •Clinical Presentation
- •Testing Recommendations
- •Treatment
- •Chancroid
- •Granuloma Inguinale aka Donovanosis
- •Herpes
- •Epidemiology
- •Clinical Presentation
- •Treatment
- •Human Papillomavirus
- •Epidemiology
- •Clinical Presentation
- •Testing
- •Treatment
- •Vaccine
- •Epidemiology
- •Testing
- •Anorectal Issues
- •Molluscum Contagiosum
- •Pubic Lice: Phthirus pubis
- •Scabies
- •20: Anal Intraepithelial Neoplasia
- •Introduction
- •Symptoms
- •Epidemiology
- •Screening/Surveillance
- •Diagnosis
- •Treatment
- •Management Strategies
- •Progression
- •Prevention
- •21: Anal Cancer
- •Anal Squamous Cell Carcinoma
- •Anal Melanoma
- •Anal Adenocarcinoma
- •22: Presacral Tumors
- •General Considerations
- •Anatomic Considerations
- •Diagnosis
- •Management
- •Outcomes
- •Chromosomal Instability
- •Microsatellite Instability
- •CpG Island Methylator Phenotype (CIMP)
- •Adenomatous Polyposis Syndromes
- •Familial Adenomatous Polyposis
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk
- •FAP Extracolonic Manifestations
- •Management
- •Screening
- •Treatment
- •Colorectal
- •Duodenal Adenomas
- •Desmoid Disease
- •Thyroid Neoplasia
- •MUTYH-Associated Polyposis
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk
- •Extracolonic Cancer Risk
- •Management
- •Screening
- •Treatment
- •Polymerase Proofreading-Associated Polyposis
- •Hamartomatous Polyposis Syndromes
- •Juvenile Polyposis Syndrome
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •Management
- •Screening
- •Treatment
- •Peutz-Jeghers Syndrome
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •Management
- •Surveillance
- •Polypectomy
- •Surgery
- •PTEN Hamartoma Tumor Syndrome (PHTS)
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk Management
- •Serrated Polyposis Syndrome (SPS)
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk
- •Management
- •Screening
- •Treatment
- •Lynch Syndrome
- •Genotype-Phenotype Correlations
- •Muir-Torre Syndrome (MTS)
- •Turcot’s Syndrome
- •Colorectal Cancer Risk
- •Other LS-Associated Cancer Risk
- •Diagnosis
- •Individual Whose Family Meets Amsterdam Criteria but Does Not Have Any Clinical Phenotype
- •Clinical Management
- •Screening
- •Introduction
- •Recommended Screening Guidelines
- •Screening Cessation
- •Colonoscopy
- •Incomplete Colonoscopy
- •Complications
- •CT Colonography (CTC) or Virtual Colonoscopy
- •Flexible Sigmoidoscopy
- •Complications
- •Fecal Occult Blood Testing (FOBT)/Fecal Immunochemical Testing (FIT)
- •Stool DNA Testing
- •Double-Contrast Barium Enema (DCBE)
- •Surveillance
- •History
- •Adenoma
- •Hamartomas Polyps
- •Early Cancer (T1) Within Polyp
- •Chemoprevention
- •Background
- •Clinical Presentation
- •Preoperative Evaluation
- •Tumor Localization
- •Total Colon Evaluation
- •Carcinoembryonic Antigen (CEA)
- •Radiographic Evaluation
- •Lymph Node Evaluation
- •Lynch Syndrome Phenotype
- •26: The Surgical Management of Colon Cancer
- •Preoperative Preparation
- •Physiologic Assessment
- •Tumor Localization
- •Surgical Technique
- •Extent of Resection
- •Mesocolic Resection
- •Right Colectomy
- •Open Approach
- •Lateral-to-Medial Approach
- •Posterior (Inferior-to-Superior) Approach
- •Superior to Inferior Approach
- •Medial-to-Lateral Approach
- •Anastomosis
- •Laparoscopic Approach
- •Medial-to-Lateral Approach
- •Posterior (Inferior-to-Superior) Approach
- •Left Colectomy
- •Open
- •Anastomotic Assessment
- •Hand-Assisted Medial-to-Lateral Approach
- •Subtotal Colectomy
- •Open Approach
- •Laparoscopic Approach
- •Total Abdominal Colectomy with Ileorectal Anastomosis
- •Special Circumstances
- •Laparoscopy
- •Obstructing Colon Cancers
- •Perforated Colon Cancers
- •Management of Primary Colon Cancer in the Setting of Distant Metastasis
- •Outcomes for Colon Cancer
- •Short-Term Outcomes
- •Long-Term Outcomes
- •Introduction
- •Total Colon Evaluation
- •Locoregional Imaging
- •Computed Tomography
- •Endorectal Ultrasound
- •T Staging
- •N Staging
- •Magnetic Resonance
- •Whole-Body Imaging
- •Computed Tomography
- •Positron Emission Tomography (PET)
- •28: Rectal Cancer: Neoadjuvant Therapy
- •Introduction
- •Historical Context
- •Postoperative Radiotherapy
- •Preoperative Radiotherapy
- •Radiosensitizing Agents
- •Preoperative Versus Postoperative Radiation
- •Short- Versus Long-Course Preoperative Radiotherapy
- •Choosing Optimal Treatment Regimens
- •The European Approach
- •Selected Adjuvant Systemic Chemotherapy
- •Selective Nonoperative Management
- •Techniques
- •Results
- •Lymphovascular Invasion
- •Tumor Budding
- •Introduction
- •Neoadjuvant Chemoradiotherapy
- •31: Proctectomy
- •Pathological Assessment
- •Preoperative Preparation
- •Operative Approaches
- •Open Low Anterior Resection (LAR)
- •Laparoscopic Low Anterior Resection
- •Robotic Low Anterior Resection
- •Abdominoperineal Resection (APR)
- •Extralevator or “Cylindrical” APR
- •Special Considerations
- •Distal Margin
- •Coloanal Anastomosis
- •Fecal Diversion
- •Extended Resection
- •Intraoperative Radiation Therapy
- •Flap Closure Following Abdominoperineal Resection
- •Functional Outcomes
- •Oncologic Outcomes
- •Multidisciplinary Rectal Cancer Care
- •32: Rectal Cancer Decision-Making
- •Assessment
- •Early Rectal Neoplasms
- •Local Excision
- •Endoscopically Excised Malignant Polyps
- •Surgical Considerations
- •Intraoperative Decisions
- •Midrectal Cancers
- •Low Rectal Cancers
- •Low Hartmann Resection Versus APR
- •Special Situations
- •Obstructing Rectal Cancer
- •Perforated Rectal Cancer
- •Synchronous Hepatic Metastases
- •33: Colorectal Cancer: Postoperative Adjuvant Therapy
- •Colon Cancer
- •Stage III Colon Cancer
- •Stage II Colon Cancer
- •Rectal Cancer
- •Patients Who Did Not Undergo Neoadjuvant Therapy
- •Patients Who Underwent Neoadjuvant Radiotherapy/Chemoradiotherapy
- •Patients Undergoing Local Excision
- •34: Colorectal Cancer: Surveillance After Curative-Intent Therapy
- •Introduction
- •Physical Examination
- •Laboratory Testing
- •Abdominal Imaging
- •Chest Imaging
- •Colonoscopy
- •Stage 1 Disease
- •Cost
- •Introduction
- •Determining Resectability
- •Multimodal Therapy Including Intraoperative Radiation
- •General Considerations
- •Recurrent Colon Cancer
- •Recurrent Rectal Cancer
- •Recurrences that Extend Anteriorly
- •Resection that Includes Sacrectomy
- •Stage I: Anterior Component
- •Stage II: Posterior Component
- •Stage III: Spinal Reconstructive Component
- •Soft Tissue Reconstruction
- •Recurrent Colon Cancer
- •Recurrent Rectal Cancer
- •Sacropelvic Resections
- •Palliative Approach
- •Introduction
- •Diagnostic Strategies
- •Computed Tomography
- •Positron Emission Tomography (PET)
- •Magnetic Resonance Imaging
- •Contrast-Enhanced Ultrasound
- •Biopsy
- •Multidisciplinary Evaluation
- •Surgical Emergency
- •Self-Expanding Intraluminal Metal Stents
- •Liver-First Strategy
- •Colon-First Strategy
- •Margin Status
- •Other Liver Metastasis Strategies: Hepatic Intra-arterial Chemotherapy/Chemoembolization
- •Pulmonary Metastasis
- •Peritoneal Metastasis
- •Ovarian Metastases
- •Bone
- •Brain
- •Pancreas
- •Adrenal
- •Retroperitoneal Lymph Nodes
- •37: Appendiceal Neoplasms
- •Introduction
- •Epidemiology
- •Epithelial Neoplasms
- •Neuroendocrine Appendiceal Lesions/Carcinoid Tumors
- •Goblet Cell Carcinoids
- •Clinical Features
- •Diagnostic Procedures
- •Medical Management
- •Appendectomy
- •Right Hemicolectomy

ab
4 Endoscopy
65
a
Fig. 4.25 Different appearances of the ileocecal valve: (a) Flat and invisible. (b) Polypoid and obvious
b
Fig. 4.26 Reaching and proper identication of the cecum is compulsory for a complete examination. (a) Round
appendiceal orice with associated crow’s foot. (b) Crescent-shaped appendiceal orice
• Careful and detailed examination of the entire
cecum is important due to the fact that many
cecal lesions, including serrated adenomas,
are at or recessed and can be quite deceptive
and easily missed with a casual examination.
ileocecal valve is hooked with the curved
endoscope, and the scope is then gently
inserted into the ileum when the lumen is
visualized (Fig.4.27).
• The addition of routine ileoscopy to screening colonoscopy has been demonstrated to
detect asymptomatic small bowel carcinoid
Ileocecal Valve Intubation
tumors and has led some to argue that this
should be considered part of the endoscopic
• It is common for some endoscopists to routinely advance the endoscope into the terminal ileum, and it is considered a critical
assessment when performing either an initial
evaluation or follow-up for Crohn’s disease or
in a search for lower gastrointestinal
bleeding.
• The technique involves rst removing any
loops from the colonoscope. The edge of the
examination.
• However in a study at the Mayo Clinic, terminal ileum intubation showed gross abnormalities in only 1% of the patients, and
pathologic abnormalities were identied for
only 0.3% of the patients. These authors
concluded that intubation of the terminal
ileum should not be a required part of screening colonoscopy.

66
K. Davis and M. A. Valente
Fig. 4.27 Intubation of the ileocecal valve: identication
of the orice, impacting the scope while giving air insufation and then waiting for the bowel to relax before
Terminal Ileum
• If the endoscopist chooses to intubate the
ileum, it is easily recognizable by noting its
granular appearance (Fig.4.28). Quite often in
younger patients, there will be innumerable
lymphoid follicles that may resemble small
polyps.
Alternate Techniques
CO2 Insuation
• Two alternatives to traditional air infusion
colonoscopy are water-assisted colonoscopy
and insufation with carbon dioxide.
• CO2 is more rapidly diffused than air, and
therefore it is expected that there will be less
pain. Some evaluations have been consistent
with this hypothesis, while others have not
shared these ndings.
Water Insuation
• It has been demonstrated in limited studies
that the use of water-assisted colonoscopy has
a positive effect on patients, predominantly
with lower levels of pain during the procedure.
In a meta-analysis of nine studies, warm water
infusion was demonstrated to be less painful
than standard air insufation while reducing
the need for sedation or analgesia during the
procedure.
advancement into the terminal ileum. (Reprinted with permission, Cleveland Clinic Center for Medical Art &
Photography ©2015. All Rights Reserved)
Fig. 4.28 Terminal ileum: note the granular mucosa and
the ne muscular folds
Chromocolonoscopy (Chromoendoscopy)
• Chromocolonoscopy involves the use of dye
with spray catheters to spray coat the colonic
mucosa in an attempt to improve the visualization abnormalities of the mucosa. There
has been some demonstrated benet with this
technology in high-risk populations such as
those with inammatory bowel disease or
those with known genetic disorders.
High-Denition/NBI Endoscopy
• High-denition endoscopes with wider-angle
viewing capability have the ability to increase
the magnication and the visualization in
endoscopy but have not proven superior in the
ability to detect additional colon neoplasms.

4 Endoscopy
67
• Narrow-band imaging (NBI) uses a lter to
narrow the blue and green wave light and
eliminates the red wavelength from standard
white light which leads to an accentuation of
the microvasculature and improved visualization of pathology. In some studies, NBI has
resulted in an increase in the number of adenomatous polyps detected and assists in better
prediction of histology. This may play a role
in the future resection and discarding of
diminutive polyps.
Full-Spectrum Endoscopy
• Full-spectrum endoscopy uses three cameras,
with the two additional cameras located adjacent to the scopes tip. The endoscopist has
simultaneous viewing images from all three
cameras. To date there is no proven benet
regarding increased adenoma detection.
Retroexion
• Many endoscopists routinely perform retroexion in the rectum.
• There is sparse data on either the benets or
the risks associated with the routine use of
retroexion of the endoscope in the rectum.
In one study of over 450 patients, retroexion
resulted nding pathology in only 9 additional cases – predominantly hyperplastic
polyps.
• In another study of over 1500 patients, only 7
polyps were visualized solely by retroexion.
Six of these were hyperplastic, and one was a
4mm sessile tubular adenoma. A higher rectal
perforation rate has been reported with the
technique.
• One study evaluating routine retroexion in
the right colon showed that it could be safely
achieved in the majority of patients undergoing screening colonoscopy.
• Retroexion identied additional polyps,
predominantly adenomas, increasing the
polyp yield as well as the adenoma detection rate in one study. Due to the concerns
regarding missed lesions in the right colon,
retroexion in patients with polyps identied on initial forward viewing should be
considered.
Complications
• Possible complications should be discussed
with the patient frankly and documented prior
to the procedure.
• The complications can be broadly grouped into
those relating directly form the procedure such
as bleeding and perforation and those relating to
the sedation involved with the procedure– primarily cardiac and pulmonary complications.
• The exact incidence of all complications varies
widely in the literature, from 4.0 for 10,000
colonoscopies to 17.8 per 1000 procedures.
The incidence of serious complications (hospital admission within 30days of the procedure)
occurs with a rate of 1 per 1000 to 5.0 per 1000
exams.
Sedation Complications
• The primary concerns regarding the administration of sedation revolve around the cardiac
and pulmonary complications associated with
these medicines.
Vasovagal/Cardiac Arrhythmia
• A vasovagal reaction is a slowing of the heart
rate, often accompanied by a drop in blood
pressure, and is believed to reect the stimulation of the vagus nerve. It occurs in up to 16%
of colonoscopies and likely results from the
distension of the bowel.
• These episodes are typically self-limited but
should be addressed by colonoscopic aspiration of air and/or reduction of loops.
• True cardiac arrhythmias are uncommon in
association with colonoscopy occurring in
approximately 2% of patients undergoing
endoscopic procedures.
• The administration of sedative medications,
particularly midazolam, causes transient
hypotension in 20% of patients, with
ST-segment depression in 7%.
• When comparing patients not having a colonoscopy, the incidence of myocardial infarction

68
K. Davis and M. A. Valente
or stroke is similar to patients undergoing
colonoscopy.
• Colonoscopy in patients with a recent myocardial infarction is associated with a higher rate
of minor, transient, and primarily cardiovascular complications compared with control
patients but is infrequently associated with
major complications.
Pulmonary
• The incidence of pulmonary complications is
even less common than for cardiac events.
Patients over 80 have higher rates of pulmonary complications.
• There are reports of aspiration following the
administration of sedative medications for
colonoscopy which is more common with
deeper sedation.
• Pneumothorax or pneumomediastinum following a colonoscopy should prompt investigation for an intra-abdominal perforation.
Procedural Complications
Splenic Injury
• The incidence of splenic injury in association
with a colonoscopy is uncommon.
• A comprehensive literature search identied
just over 100 patients worldwide with this
complication.
• It is believed that the etiology of this injury is
from traction and subsequent tearing of the
splenocolic ligament during the procedure,
with subcapsular hematoma the most common
injury pattern seen.
• Splenic rupture at colonoscopy usually presents with abdominal pain developing within
the rst 24h.
• The majority of patients described in the literature have required splenectomy.
Perforation
1. A perforation of the colon during a colonos-
copy can be a devastating complication that
can result in serious morbidity or mortality.
The incidence of perforation is reported to be
between 0.012% and 0.016% in large
studies.
2. There are three mechanisms responsible for
colonoscopic perforation:
• Mechanical perforation resulting from
direct trauma from the colonoscope which
occurs more commonly in the sigmoid
colon
• Barotrauma from air insufation which
occurs more commonly in the ascending
colon or cecum, which would be the most
susceptible to this mechanism
• Therapeutic procedures such as polypec-
tomy (thermal injury or full-thickness
excision) or the dilation of strictures
3. Management of perforations depends on its
etiology and the condition of the patient.
4. If the patient presents acutely and has peritonitis, the management is relatively clear, and
the patient warrants an emergent laparotomy.
5. If the patient had a therapeutic endoscopy
and is clinically stable, then an attempt at
non-operative management (IV antibiotics,
bowel rest) is acceptable.
6. Perforations from a diagnostic colonoscopy
are likely larger and are less successfully
managed with non-operative treatment
unless the perforation is immediately recognized and repaired endoscopically.
7. If the patient requires surgical intervention,
primary repair or resection with a primary
anastomosis has proven to be an effective
management strategy.
8. One emerging technology is the use of clips to
manage a perforation that is either identied
endoscopically or as prophylaxis when the
endoscopist feels that the depth of resection
from a polypectomy makes perforation likely.
9. A literature review of perforations managed
with this technology shows that if the clips
were placed for a perforation during therapeutic colonoscopy, it is successful in
69–93% of cases.
10. This technology has a place in the endoscopist’s armamentarium but should also be
employed with surgical consultation, so that
early decisions regarding operative management can be made.

4 Endoscopy
69
Post-polypectomy Syndrome
• Post-polypectomy syndrome is a spectrum of
symptoms including abdominal pain, fever,
leukocytosis, peritoneal tenderness, and guarding, following a colonoscopic polypectomy.
• It is believed to be the result of an electrocoagulation injury to the colonic wall, thereby
creating a transmural burn with localized peritoneal inammation, but without evidence of
perforation. Patients present up to several days
following a colonoscopy with fever, localized
abdominal pain, and leukocytosis and may
have localized peritoneal signs on physical
examination. The majority of these patients do
not require surgical treatment and are usually
adequately managed with bowel rest, intravenous hydration, and broad-spectrum parenteral antibiotics until symptoms resolution.
Bleeding
• Bleeding following a polypectomy is the most
common serious complication following a
colonoscopy (3% of cases).
• Patients should be given specic written
instructions regarding the actions they should
take if it should occur.
• Immediate bleeding is dealt with by the endoscopist at the time of the procedure. Clinically
signicant post-polypectomy hemorrhage
typically manifests itself 4–6 days following
the procedure but may occur up to 14 days
post-procedure.
• Risks for post-polypectomy bleeding include
difcult procedures with procedural bleeding,
patients on anticoagulation, hypertension,
right-sided polyps, larger polyps, and pedunculated polyps with a thicker stalk. Factors
which don’t impart an increased risk of bleeding include aspirin, NSAIDs, or polyp morphology (sessile vs pedunculated)
• The initial management of a patient with postpolypectomy bleeding is identical to any
patient with intestinal bleeding and includes
measurement of coagulation parameters and
resuscitation based upon hemodynamic
parameters.
• Most patients can be managed with a repeat
endoscopy if there is evidence of ongoing
hemorrhage. Commonly employed hemostatic
techniques are hemostatic clips, epinephrine
injection, and electrocautery.
• Angiographic embolization has been demonstrated to be effective in the management of
post-polypectomy bleeding.
• Endoscopic clipping has been demonstrated
benecial in patients at increased risk for postpolypectomy hemorrhage. One study demonstrated a signicantly decreased rate of
post-procedure bleeding for polyps >2 cm
when the site was prophylactically clipped.
Another report showed clipping to be benecial
in anticoagulated patients with lesions larger
than 1cm who were able to undergo successful
polypectomy without interrupting the anticoagulation or antiplatelet medications.
Infectious Complications
• The endoscopist should have a basic understanding of the process involved in the cleaning of the endoscopes and endoscopic
equipment, as the majority of the rare infectious complications result from breaches in
cleaning procedures.
• Salmonella, Pseudomonas, and Myco-
bacterium species are the most commonly
transmitted organisms associated with endoscopic equipment, and the ability of these bacteria to form biolms on the inner channel
surfaces is believed to contribute to their ability to survive the decontamination process.
• The endoscopist should always be vigilant
regarding the equipment used and ensure that
proper protocols are in place and are being
followed.
Training andtheUse ofSimulation
• The criteria of what constitutes adequate training to perform colonoscopy is controversial.
• There are differences in the way gastroenterologists and surgeons educate and evaluate
their trainees in performing procedures.

70
K. Davis and M. A. Valente
• Most of the literature on the topic involves gastroenterology fellows and tends to focus on the
number of procedures necessary in order to
achieve competency. In evaluating gastroenterology fellows, it was found that the ability to
intubate the cecum successfully improved and
reached the requisite standard of competence–
dened as completing the task greater than
90% of the time and within 20min after 150
procedures had been performed. An independent completion rate of 90% was not obtained
until after 500 colonoscopies were performed.
As with the ability to technically perform the
procedure, quality metrics of trainees also
improve with experience as well.
• In one of the few comparisons between gastroenterology and surgery trainees, there was
a disparity in endoscopic performance
between trainees favoring the gastroenterology trainees although a separate study showed
that following the use of endoscopy simulation, surgery residents were capable of performing colonoscopy equivalent to their
gastroenterology counterparts using quality
metrics as the benchmark.
Simulation
• The practice of endoscopy lends itself well to
simulation, yet it has not been fully embraced.
The improvement of trainees using simulation
is most noticeable during the beginning of their
endoscopic experience. Following a 6-h colonoscopy simulation, trainees were noted to signicantly outperform those who did not have
the training, but these advantages are negligible
after approximately 30 procedures on patients.
Documentation andQuality
Documentation
• After completion of the procedure, it is important to adequately document any ndings as
well as any adjunctive procedures that were
performed at the time.
• It is imperative to photo-document any lesions
or that were biopsied and describe their size
and morphology, location, completeness of
removal and the endoscopists interpretation of
these lesions.
• A Multi-Society Task Force on Colorectal
Cancer developed a consensus-based set of
data points that reected what should be
included in any colonoscopy report (Table4.3).
There are numerous commercially available
software programs that allow rapid and accurate documentation, and these guidelines will
look familiar to any provider who has utilized
these systems. Attention to detail is required
to enter accurate information that will be
relayed to the patient and any other treating
physicians.
Quality
• There is increasing attention to quantiable
measures of quality in medicine, and colonoscopy lends itself well to metric analysis, and
therefore there has been a great deal of attention paid to these performance measures.
• The ve most frequently cited quality measures are cecal intubation rate, adherence to
recommended screening and surveillance
interval, adenoma detection rate, quality of
bowel preparation, and colonoscopy withdrawal time.
PillCam Endoscopy
• The advent of PillCam endoscopy (PCE) has
revolutionized the evaluation of the small
intestine. It allows the clinician to evaluate
this portion of the intestine that was previously relegated to inaccurate or uncomfortable studies such as small bowel radiographic
series or enteroclysis.
• The procedure is most commonly used in
patients with occult gastrointestinal bleeding
or in the search for other small bowel pathologies, such as insipient tumors, polyposis syndromes, or Crohn’s disease.

4 Endoscopy
Table 4.3 Recommended elements in standard colonoscopy report
Documentation of informed consent
Facility where endoscopy performed
Patient demographics and history
Age/sex
Receiving anticoagulation: if yes, document management plan
Need for antibiotic prophylaxis: if yes, document reason and management plan
Assessment of patient risk and comorbidity
ASA classication
Indication(s) for procedure:
Procedure: technical description
Procedure date and time
Procedure performed with additional qualiers (CPT codes, polypectomy, etc.)
Sedation: medications given and by the type of provider responsible
Level of sedation (conscious, deep, general anesthesia)
Extent of examination by anatomic segment: cecum, ascending colon, etc.
If cecum is not reached, provide reason
Method of documentation: i.e., photo of ileocecal valve and/or appendiceal orice
Time of examination: scope was inserted, withdrawal started, when withdrawn from patient
Retroexion in rectum (yes/no)
Bowel prep: type of preparation, quality, adequate, or inadequate to detect polyps >5mm
Technical performance: not technically difcult or examination difcult
Patient discomfort/looping/need for special maneuvers including turning patient
Type of instrument used: model and instrument number
Colonoscopic ndings
Colonic masses or polyp(s)
Anatomic location: length/size, mm
Descriptors: pedunculated/sessile/at/obstructive (% of lumen reduced)/ulcerated
Biopsy obtained: hot/cold or snare/tattoo (if performed)
Fulguration or ablation with cautery
Completely removed (yes/no)/retrieved (yes/no)/sent to pathology (yes/no)
Mucosal abnormality:
Suspected diagnosis: ulcerative colitis, Crohn’s, ischemia, infection
Anatomic location/extent/pathology obtained (yes/no)
Other ndings:
Diverticulosis/arteriovenous malformations/hemorrhoids
Assessment:
Follow-up plan:
Immediate follow-up/further tests, referrals/medication changes
Follow-up appointments and recommendation for follow-up colonoscopy and tests
Documentation of communication directly to the patient and referring physician
Pathology:
Pathology results reviewed, communicated with referring provider with recommendation for follow-up and
communicated with patient
Adapted from Lieberman D, Nadel M etal. Standardized colonoscopy reporting and data system: report of the Quality
Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc 2007 May;65(6):757–66. (17)
71
• It is typically performed after an upper and
lower endoscopic examination has already
been completed. However it can complement
them as well, as in at least one study, 28% of
abnormalities identied on PCE were within
the area normally covered by an endoscopic
exam.
• Capsule endoscopy does not require a bowel
preparation, but most patients are instructed to
remain either NPO or on a clear liquid diet for

72
K. Davis and M. A. Valente
10–12h prior to the procedure. The patient swallows the disposable capsule, which then transmits images wirelessly to a recorder, and the
clinician can review the images at a time when it
is convenient to spend the 15–60min, on average, for image viewing and documentation.
• While there are concerns for evaluating
patients with stricturing Crohn’s disease, as
the capsule can be retained at the location of a
stricture, this is typically less of a concern for
a surgeon contemplating operative management and can serve as a marker of stricture
location enabling the procedure to be performed with minimally invasive techniques.
PCE has resulted in medication changes in up
to 60% of patients in some studies and has
proven superior to other imaging modalities in
identifying obscure sources of intestinal
bleeding and is benecial in the localization of
small bowel neoplasms.

Endoscopic Management
ofPolyps, Polypectomy,
andCombined Endoscopic
andLaparoscopic Surgery
KellyA.Garrett andSangW.Lee
5
Key Concepts
• Colonoscopic polypectomy is the treatment of
choice for diagnosing and removing most
colon polyps.
• Operator variability inuences the quality of
colonoscopy for both detection and resection.
• Multiple questions remain about best practice
techniques for colonoscopic polypectomy.
• EMR of colorectal lesions is safe and effective
but results in piecemeal resection that may
prevent accurate histological diagnosis. Colonoscopy surveillance is required to assess for
and manage local recurrence of neoplasia.
• ESD is able to resect supercial lesions en
bloc regardless of tumor size, location, and
brosis. These advantages come at a cost of an
increased risk of perforation, bleeding, and a
longer procedure time as compared with
EMR.
• Combined endo-laparoscopic surgery is an
adjunct to endoscopic polypectomy that may
help to avoid colectomy.
Electronic Supplementary Material The online
version of this chapter (https://doi.org/10.1007/978-3-
030-01165-9_5) contains supplementary material, which
is available to authorized users.
Introduction
• Colon cancer is the third most common cause
of cancer-related mortality in the United
States.
• In 2015 there were estimated 93,090 new
cases of colon cancer with almost 50,000
deaths due to colon cancer.
• There has been a steady decline in the colorectal cancer incidence since the mid-1980s
which is partially attributed to the introduction
of colorectal cancer screening.
• There has even been a more rapid decline in
recent years (4% or greater per year from 2008
to 2011) which may be multifactorial but
likely reects the increased use of screening
colonoscopy. Among adults aged 50–75years,
colonoscopy use increased from 19.1% in
2000 to 54.5% in 2013.
• Colonoscopic polypectomy is the treatment of
choice for diagnosing and removing most
colon polyps.
• Large polyps or polyps in an anatomically difcult location can be challenging to remove
endoscopically. Traditionally the most common recommendation for these patients has
been to undergo a colon resection.
K. A. Garrett
Department of General Surgery, Section of Colon and
Rectal Surgery, Weill Cornell Medical College,
NewYork Presbyterian Hospital,
New York, NY, USA
© ASCRS (American Society of Colon and Rectal Surgeons) 2019
S. R. Steele et al. (eds.), The ASCRS Manual of Colon and Rectal Surgery,
https://doi.org/10.1007/978-3-030-01165-9_5
S. W. Lee (*)
University of Southern California,
Los Angeles, CA, USA
e-mail: sangwl@med.usc.edu
73

74
K. A. Garrett and S. W. Lee
Identication ofPolyps
• Indicators of quality colonoscopy include
cecal intubation, withdrawal time, and polyp
detection rate.
• Low cecal intubation rates have been associated with higher rates of interval proximal
colon cancers.
• Colonoscopy studies in screening patients in
the United States have reported cecal intubation rates of 97% or higher.
• The US Multi-Society Task Force on Colorectal Cancer recommended a withdrawal time
(dened as the time from cecal intubation to
the time the colonoscope is withdrawn out of
the anus) of at least 6min as an indicator of
quality colonoscopy.
• A correlation between longer withdrawal time
and an increased rate in the detection of adenomas has been demonstrated.
• The American Society for Gastrointestinal
Endoscopy (ASGE) and the American College of Gastroenterology (ACG) recommend a
minimum target for overall adenoma detection
rate (ADR) of at least 25% based on the observation that higher ADRs were associated with
a reduced risk of both proximal and distal
cancers.
Criteria forPolypectomy
• Polyps should be removed as any adenomatous tissue visualized should be assumed to
carry some malignant potential.
• More than 95% of colorectal cancers arise
from adenomatous polyps (adenoma to carcinoma sequence) in a process that may take
many years.
• Polyps are characterized by their size and
morphology (pedunculated or sessile).
• An advanced adenoma is one that is ≥1cm in
size or contains high-grade dysplasia or appreciable villous tissue.
• The prevalence of advanced adenomas is 6–9%
for average-risk screening colonoscopy.
• The malignant potential of adenomas <0.5cm
is not as well studied.
• A retrospective study analyzed 7590 adenomatous polyps. Size was the strongest predictor of advanced pathologic features
(high-grade dysplasia or invasive cancer). The
percentages of adenomas with advanced
pathologic features were 3.4%, 13.5%, and
38.5% for adenomas <0.5 cm, 0.5–1.0 cm,
and> 1cm, respectively. Villous change, leftsided location, and age ≥60 were also associated with advanced pathologic features.
• If there are characteristics suspicious for
malignancy (induration, mucosal irregularity,
vascular pattern on narrow band imaging,
ulceration or central umbilication, large size,
failure to lift with submucosal injection), a
polypectomy should not be performed.
• Large polyp size (without other concerning
features) may be a reason to defer polypectomy due to higher risk of perforation during
resection.
• A polypectomy should not be performed if the
risks outweigh the benets, for example, short
life expectancy or signicant comorbidites.
Polypectomy Techniques
• The principles of polypectomy are to remove
all visible adenomatous tissue, but there are
many different techniques that are used which
create a wide variability in practice.
• Polypectomy is best performed with the polyp
in the 5–7 o’clock position.
• Cold biopsy forceps is the simplest method of
polypectomy and is frequently used for
diminutive lesions (polyps <5 mm). The
biopsy forceps is passed through the biopsy
channel of the colonoscope, and the jaws are
positioned over the polyp which is grasped,
removed, and retrieved. More than one bite
may be needed to remove all polypoid tissue.
Minor bleeding may occur and there is an
insignicant risk of perforation. Residual
polyp tissue is present in 29–38% of
specimens.
• Comparison of jumbo forceps (jaw volume
12.44mm3) to standard forceps (jaw volume
7.22 mm3) showed a higher complete
Соседние файлы в папке Библиотека им академика М.И. Перельмана
